California voters hand $4B to a three-person institute still seeking a director
What's the deal? California voters approved Proposition 38 on November 3, authorizing the state to borrow $8.4 billion for immunology and immunotherapy research. Half — more than $4 billion — is reserved for a single nonprofit that still has no named director and currently employs three people.
Who qualifies? The measure names no recipient, but its eligibility criteria match only one organization: the California Institute for Immunology and Immunotherapy (CIII). A UCLA spokesperson told CalMattersDealroom has a profile for this one. Try Dealroom → that, among nonprofits affiliated with the university, only CIII meets them.
Who's behind it? CIII is chaired by billionaire Gary Michelson, who wrote the ballot measure and funded nearly the entire campaign. A Yes on 38 spokesperson said it is "very likely" that CIII will qualify under the current criteria.
Why the staffing matters: In September, UCLA Health CEO John Mazziotta, who sits on CIII's board, told UC regents the institute had hired three employees: a chief operating officer, a general counsel, and a scientific adviser. Its most recent Form 990 filings, covering the year ending June 2025, list zero employees — despite a five-year business plan that called for dozens of hires by this point.
What's missing: No director has been named, and the scientific adviser's identity has not been disclosed. The building meant to house the institute, at the former Westside Pavilion near UCLA, is not expected to be finished until at least mid-to-late 2028.
What could go wrong? The state has already spent about $200 million on the site and needs roughly $100 million more for construction, according to Mazziotta. Taxpayers will repay the bonds from the General Fund at an estimated $500 million to $600 million a year for about two decades. The California Department of Public HealthDealroom has a profile for this one. Try Dealroom → is responsible for evaluating applicants against the eligibility rules.
The signal: The funding could boost research amid uncertainty over federal science support. But the gap between a multibillion-dollar mandate and a three-person team makes the coming leadership appointments and the state's readiness review consequential — not routine personnel news.
Read more: wnd.com
Image credit: "2010 DNA Distribution" by igemhq, licensed under CC BY 2.0